Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-REACT: Intraarterial Thrombolysis After Thrombectomy in Acute Ischemic Stroke
NCT07687056Phase 3Recruiting
- Sponsor
- University of Calgary
- Start
- Aug 2026
- Primary completion
- Dec 2030
- Countries
- 2
01
Overview
A Phase 3 trial of tenecteplase, tissue-plasminogen activator in ischemic stroke, sponsored by University of Calgary. Started Aug 2026; status: recruiting.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07687056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07687056.